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Summa", End-to-side ponacaval shunts were Carried 
out in three children with the liver disease of 
alpha-I-antitrypsin deficiency and complications of ponal 
hypenension. Their clinical courses have been stable for 311z 
to almost 7 years. Postoperative liver biopsy material from 
two of the patients showed the typical histopathological 
changes caused by portal diversion, as well as an apparent 
reduction in the quantity of alpha-I-antitrypsin particles in 
the hepatocytes. The metabolk changes caused by ponal 
diversion have apparently created a more favourable 
equilibrium between the synthesis and excretion of the 
abnormal al pha-I-antitrypsin. 
Introduction 
THE ponacaval shunt has conventionally been used to treat 
the complications of ponal hypenension, ascites and 
haemorrhage from oesophageal varices. Livers deprived by 
portacaval shunt of hormones, and probably other 
substances, in ponal venous blood undergo subtle but 
profound changes in function. l -4 Because these changes in 
hepatic function occur, portal diversion can improve the 
condition in two inborn errors of metabolism-glycogen 
storage disease,,5 and familial hypercholesterolaemia.4•6 
W enow report a third example of metabolic engineering by 
end-to-side portacaval shunt in three children with liver 
disease associated with alpha-I-antitrypsin deficiency. 
Caae-repom 
Patientl 
A German girl aged 4 years 8 months was referred for 
consideration ofliver transplantation because of alpha-I-antitrypsin 
deficiency (PiZZ phenotype), hepatic cirrhosis, moderate ascites, 
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and a haemorrhage from oesophageal varices that had required five 
transfusions. Her sister had died of the same disease aged five years. 
Both children had had neonatal jaundice which subsided 
spontaneously. The patient's liver function test results were 
bilirubin 25· 6 ",moUI, serum aspartate aminotransferase 150 lUll 
(normal <50), serum alanine aminotransferase 260 lUll (normal 
<50), alkaline phosphatase 1800 lUll (normal <250), prothrombin 
time 12 s (II' 5 s control), total protein 63 gil with 33 gil albumin, 
serum alpha-I-antitrypsin 300 mg/l (normal >2000), serum 
ammonia 58·7 ",moUI (normal <50). 
End-to-slde portacaval shunt was carried out on June IS, 1976. 
The liver was moderately enlarged and had macronodular cirrhosis. 
Mter operation the patient became jaundiced, with a peak bilirubin 
of 103 ",moUI, but the icterus slowly disappeared over several 
months. The ascites was relieved and there have been no further 
gastrointestinal haemorrhages. At the time of operation, the child's 
position on the Harvard growth rurv~ was at the 5th weight 
percentile and the 50th height percentile. In the past 6lf. years, her 
weight and height positions have moved to the 50th and 70th 
percentiles, respectively. Recent liver function test results, 
including serum alpha-I-antitrypsin concentrations, are similar to 
preoperative results, with bilirubin in the range 20-30 ",molii. 
Serum arrunotransferase and alkaline phosphatase levels are less 
elevated than previously, but the serum ammonia level has risen to 
58-Ill ",moili. As advised. the patient avoids a high-protein diet 
and has had no evidence of hepatic encephalopathy. She is a good 
student. 
Patient 2 
This girl had transient neonatal jaundice and cirrhosis later 
developed. Alpha-I-antitrypsin deficiency (PiZZ phenotype) was 
proved when she was 41;' years old. Because of repeated variceal 
haemorrhages and mild ascites, end·to-side portacaval shunt was 
carried out on March 7. 1978. when she was 6111 years old. Before 
operation her liver function test results were bilirubin 30· 8 ",molll, 
prothrombin time 13 s (II s control), total protein 52 gil with serum 
albumin 35 gil. serum alpha-I·antitrypsin 160 mgll and serum 
ammonia 29-53 ",moUI. Serum aminotransferase and alkaline 
phosphatase levels were 2-6 times higher than normal. 
Her liver disease slowly became worse for the first 3'h years after 
operation. as judged mainly by serum bilirubin concentrations that 
reached a peak of 51-82 ~morf in mid-1981; subsequently, total 
bilirubins fell to 43 ",moUI. Total protem is now 62 gil with 40 gil 
albumin. Prothrombin time is still longer than normal (12 to 13 s) 
and serum arrunotransferase and alkaline phosphatase levels are 
slightly raised. Serum alpha-I-antitrypsin concentrations have not 
changed. Serum ammonia levels are 53-88 ",molll on an 
unrestricted diet but can be kept in the normal range with a low-
protein diet. The patient receives diuretics to prevent ascites but she 
has not had encephalopathy. She is a fair student. Her growth 
pattern in the 5 postoperative years has changed. Her height 
position has moved from the 10th to the 60th percentile on the 
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growth curve and her weight position from the 50th to 25th 
percentile. 
Patient 3 
A boy born in September, 1978, had neonatal jaundice for several 
months followed by hepatic cirrhosis and ascites. The diagnosis of 
alpha-I-antitrypsin (PiZZ phenotype) deficiency was established. 
The semm concentration of alpha-I-antitrypsin was 300 mg/I. 
Serum bilirubin, prothrombin time, serum albumin, and serum 
ammonia were normal. The aminotransferase and alkaline 
phosphatase levels were high, as in patients I and 2. 
On Nov I, 1979, when [he boy was 13 1h months old, an end-to-
side portacaval shunt was carried out. Management of the ascites 
with diuretics was extremely difficult for the first few months, but 
not thereafter. For the 3112 years of follow-up, liver function test 
results have been the same as before operation except for rises in 
fasting serum ammonia to approximately 60 ",moUI. Mental 
development has been normal. The weight and height positions on 
the Harvard growth scale are at the 55th and 30th percentiles, 
respectively, about the same as before the operation. 
Histopathology 
We did liver biopsies on all three patients at the time of 
ponacaval shunt. Repeat biopsy samples were obtained in 
patient 2 after 9 months and in patient 3 after 7, 13, and 35 
months. Each specimen was divided; the larger pan was flXed 
in buffered formalin and the smaller in glutaraldehyde. 
Paraffin sections were prepared. and stained with a range of 
reagents, including periodic acid schiff (PAS), used after the 
section had been treated. with diastase. A peroxidase-anti-
peroxidase (PAP) technique with specific antibody 
(Dakopatts, Denmark) was used to identify alpha-I-
antitrypsin. Ultra-thin sections were prepared and examined 
in a Phillips EM 300 electron microscope. 10 000 
hepatocytes were measured in each biopsy sample by a 
standard morphometric technique.! The proponion of these 
hepatocytes with diastase-resistant PAS-positive granules in 
the cytoplasm was recorded. 
The initial biopsy samples revealed macronodular cirrhosis 
in each patient. The livers also contained multiple, round, 
PAS-positive bodies in the hepatocyte cytoplasm. Most of the 
bodies were small and the number per cell varied 
considerably. They were intensely PAS-positive, resisted 
diastase digestion, and contained alpha-I-antitrypsin as 
demonstrated by the PAP technique. The bodies were more 
frequent at the periphery of the pseudolobules. 
The biopsy sample from patient 2 taken 9 months after 
operation had a similar appearance, but the percentage of 
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hepatocytes containing alpha-I-antitrypsin globules was 
lower (28, 5% compared with 38·2% when portacaval shunt 
was done), the hepatocytes were 22% smaller, and the amount 
of rough endoplasmic reticulum was greatly reduced. 
In patient 3 the percentage ofhepatocytes containing alpha-
I·antitrypsin globules was 44·5% at operation and 48·20/0 
and 38' 7% 7 months and 13 months later. The hepatocytes 
were 15% and 20% smaller in the postoperative biopsy 
samples. The percentage of hepatocytes containing alpha-I-
antitrypsin globules had fallen to 20' 4% in the biopsy sample 
taken at 35 months. The hepatocytes remained 20% small.er 
than in the preoperative sample and the amounts of rough and 
smooth endoplasmic reticulum were reduced. The severity of 
the macro nodular cirrhosis was unaltered. 
Discussion 
In alpha-I-antitrypsin deficiency, the liver synthesises an 
abnormal variant/·9 which apparently cannot be efficiently 
transported from the hepatocyte to the bloodstream and 
becomes concentrated near the rough endoplasmic 
reticulum. 10 It is thought to stimulate the fibrous reaction and 
eventual cirrhosis that are frequent but variable features of 
the disorder. 11 ,12 Liver transplantation has been the only 
decisive method of treatment; transplantation relieves 
hepatic failure and raises serum alpha-I·antitrypsin levels to 
normal, and the patients receive new protease inhibitor 
types. 13,14 
We have speculated previously15 on the possibility that 
portal diversion might offer metabolic palliation to some of 
these patients at an earlier stage of disease. The stable 
condition of the three patients reported here for several years 
after portacaval shunt compared with their progressive 
deterioration before operation is consistent with this 
prediction. Similar long survival of two children after central 
splenorenal shunt for variceal haemorrhage has been 
described by Sotos et al. 16 However, the most objective 
evidence that the history of the hepatic disease was favourably 
altered came from the histopathological studies. The number 
ofhepatocytes with cytoplasmic alpha-I-antitrypsin globules 
fell in both patients for whom repeat biopsy samples were 
available. This fall could have been due to the biopsies being 
unrepresentative. This explanation is, however, unlikely 
because the distribution of alpha-I-antitrypsin globules 
throughout the liver tends to be uniform, even though the 
location of the· granules with lobules and cirrhotic 
pseudolobules varies. It seems unlikely that the number and 
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size of PAS-positive alpha-I-antitrypsin granules would 
decrease spontaneously. In both patient 2 and patient 3 the 
cirrhosis had neither progressed nor regressed. 
The demonstration that ponal venous blood contains 
hepatotrophic constituents, of which endogenous insulin is 
the most imponant,1-4 helps to explain the consequences of 
ponacaval shunt. In all species studied so far, including man, 
ponal-systemic diversion of these hepatotrophic substances 
causes a characteristic and serious liver injury with 
hepatocyte atrophy, glycogen depletion, fatty infiltration, 
and drastic alteration of the organelies. I '4,6 Some of these 
features were seen in the postoperative biopsy specimens 
from our patients. The reduction in hepatocyte rough 
endoplasmic reticulum with depletion of its polyribosomes is 
the most specific ultrastructural change; it provides at least a 
panial explanation of the depression after ponacaval shunt of 
many biosynthetic processes,4 including lipid and bile-acid 
production, the Krebs·Henseleit cycle, and activities of the 
microsomal mixed-function oxidase system. 
Since alpha-I-antitrypsirr is synthesised principally on 
ribosomes bound to the rough endoplasmic reticulum, 17.18 its 
production also should be reduced by ponacaval shunt. The 
glycoprotein is secreted through the channels of the smooth 
endoplasmic reticulum and Golgi complex,17,18 structures 
which are not severely damaged by ponal diversion. I•4,6 
Thus, the liver damage associated with alpha-I-antitrypsin 
deficiency may be lessened after ponal diversion by a 
favourable change in the equilibrium between hepatic 
synthesis and excretion of alpha-I-antitrypsin, without 
causing any change in the serum level of the glycoprotein. 
Exploitation of this concept in clinical care may be 
exceptionally difficult. The maiority of patients with alpha-I-
antitrypsin deficiency do not progress to significant hepatic 
disease even though their livers are crammed with the 
abnormal glycoprotein. 11,12 At the other extreme, ponacaval 
shunt for metabolic objectives would be futile in patients with 
end-stage cirrhosis. Bismuth et al 19 reponed the death of a 
child with alpha-I-antitrypsin deficiency in whom 
progressive encephalopathy and hepatic failure developed 
after portal diversion. The pauents for whom ponal diversion 
may be suitable are those who still have good liver function 
and hepatopetal flow but In whom cirrhosis and portal 
hypertension are developing. 
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